Many lines of evidence suggest that brain tissues from AD patients were exposed to oxidative stress such as glycoxidation, protein, lipid and DNA oxidation during the development of the disease, and this is at least via inhibiting PP2A activity and activating GSK3β [19–21]. This evidence concerns the gene PTPA and Alzheimer disease.